Chu Saint Etienne Hopital Nord
Saint-Priest-en-Jarez 42277
2 studies enrolling now · 15 studies all time
What they study most
Chronic Thromboembolic Pulmonary Hypertension, Colitis, Ulcerative, Crohn Disease, Depressive Disorder, Major, Hepatocellular Carcinoma (HCC), IgA Nephropathy, Immunoglobulin A Nephropathy, Invasive Extraintestinal Pathogenic Escherichia Coli Disease (IED) Prevention, Pouchitis, Pulmonary Arterial Hypertension, Sjogrens Syndrome, Ulcerative Colitis
Studies at this site
- A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis — Recruiting now
- A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease — Recruiting now
- A Study of Guselkumab Subcutaneous Therapy in Participants With Moderately to Severely Active Crohn's Disease — Running, not enrolling
- Nipocalimab in Moderate to Severe Sjogren's Disease — Running, not enrolling
- A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis — Running, not enrolling
- A Study of Guselkumab Therapy in Participants With Moderately to Severely Active Ulcerative Colitis — Running, not enrolling
- Outcome Study Assessing a 75 Milligrams (mg) Dose of Macitentan in Patients With Pulmonary Arterial Hypertension — Running, not enrolling
- A Study of Vaccination With 9-valent Extraintestinal Pathogenic Escherichia Coli Vaccine (ExPEC9V) in the Prevention of Invasive Extraintestinal Pathogenic Escherichia Coli Disease in Adults Aged 60 Years And Older With a History of Urinary Tract Infection in the Past 2 Years — Completed
- Atrasentan in Patients With IgA Nephropathy — Running, not enrolling
- A Study of JNJ-77242113 in Participants With Moderately to Severely Active Ulcerative Colitis — Completed
- A Study of Tislelizumab Versus Sorafenib in Participants With Unresectable Hepatocellular Carcinoma (HCC) — Completed
- A Study to Evaluate Efficacy and Safety of Macitentan 75 mg in Inoperable or Persistent/Recurrent Chronic Thromboembolic Pulmonary Hypertension — Stopped early
- 54135419SUI3002: A Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Participants Assessed to be at Imminent Risk for Suicide — Completed
- Study of the Safety and Efficacy of AMT-101 in Subjects With Pouchitis — Completed
- A Study to Evaluate the Efficacy and Safety of Vedolizumab in the Treatment of Chronic Pouchitis — Completed